| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −477.6× | −1.7× | |
| Price / Book | 5.1× | 2.0× | |
| Price / Sales | 1.2× | 4.0× | |
| Price / Free cash flow | 24.0× | −1.6× | |
| EV / EBITDA | 48.9× | −1.2× | |
| Earnings yield | −0.2% | −14.4% | |
| Free cash flow yield | 4.2% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,298.18 | +4.66% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.75 | +2.35% | $625.97B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.76 | +2.15% | $510.27B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $419.70 | +3.15% | $376.72B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.27 | +3.23% | $365.81B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.34 | +2.09% | $282.67B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.47 | +2.76% | $261.28B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $683.52 | +0.61% | $252.73B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.00 | +2.37% | $235.17B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.34 | +2.14% | $193.85B | 22.3× | 37.5% | +29.9% |
